RAINBOW Rainbow Childrens Medicare Q3 FY25 results (Oct–Dec 2024) and concall
Rainbow Children's Medicare delivered a strong Q3 FY25 performance with double-digit growth across revenue and profitability, despite seasonal variations and international business challenges. The company is aggressively pursuing a hub-and-spoke expansion strategy, targeting 1,000 additional beds in the next 3.5 years, primarily through internal accruals. While international medical tourism saw a sharp decline due to geopolitical tensions, domestic demand and the ramp-up of new facilities in Hyderabad, Bangalore, and Chennai continue to drive momentum.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 |
|---|---|---|
| Revenue | 417 | 398 |
| EBITDA | 147 | 134 |
| Net profit | 79 | 69 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
